Hologic Inc (BSP:H1OL34)
R$ 447.04 0 (0%) Market Cap: 103.83 Bil Enterprise Value: 105.01 Bil PE Ratio: 23.66 PB Ratio: 3.57 GF Score: 87/100

Hologic Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2020 / 02:30PM GMT
Release Date Price: R$208.7
Amit Hazan
Goldman Sachs Group, Inc., Research Division - Equity Analyst

All right. Good morning, everyone. We're back. I'm Amit Hazan, the medical technology analyst at Goldman Sachs. From my team, Jamie and Phil are probably on in the background as well. And we're excited to have as our next presenter, Hologic, a company we actually don't cover, but I used to back in the day. And so we've got Steve MacMillan, the Chairman, President and Chief Executive Officer, with us this morning; and Mike Watts might chime in as well, Vice President, Investor Relations. And so first and foremost, these are busy times for you guys, Steve. So I must say thank you so much for joining us, and welcome.

Stephen P. MacMillan
Hologic, Inc. - Chairman, CEO & President

Well, thank you, Amit. Good to see you again after all these years.

Amit Hazan
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Yes. Likewise. My history with Hologic goes back a long way. It was a small-cap stock and Cytyc and Gen-Probe are all names I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot